These benefits, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two aid the idea of focusing on ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked Diseases. Disclaimer: The above mentioned https://paulp504cwq4.blogsmine.com/profile